Log In
Print this Print this

Biaxin, Clarith, clarithromycin

  Manage Alerts
Collapse Summary General Information
Company Taisho Pharmaceutical Holdings Co. Ltd.
Molecular Target Ribosomal 50S subunit
Mechanism of ActionRibosomal 50S subunit inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationBacterial respiratory infection
Indication DetailsTreat bacterial respiratory infection
Regulatory Designation
PartnerAbbott Laboratories;
AbbVie Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today